Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125226101 | 12522610 | 1 | I | 20160621 | 20160701 | 20160701 | EXP | TW-BAYER-2016-122701 | BAYER | LIAO C-Y; SU K-J; LIN C-H; HUANG S-F; CHANG C-W; KUO W-H; BEN R-J; YEH Y-C; CHIN H-K. PLANTAR PURPURA AS THE INITIAL PRESENTATION OF VIRIDIANS STREPTOCOCCAL SHOCK SYNDROME SECONDARY TO STREPTOCOCCUS GORDONII BACTEREMIA. CANADIAN JOURNAL OF INFECTIOUS DISEASES AND MEDICAL MICROBIOLOGY. 2016;2016:5 PAGES | 54.00 | YR | A | F | Y | 0.00000 | 20160701 | OT | TW | TW |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125226101 | 12522610 | 1 | PS | CIPROFLOXACIN BETAIN | CIPROFLOXACIN | 1 | 400 MG, EVERY 12 H | 19847 | 400 | MG | SOLUTION FOR INFUSION | ||||||||
125226101 | 12522610 | 2 | SS | CEFTRIAXONE. | CEFTRIAXONE | 1 | 2.0 G, QD | 0 | 2 | G | QD | ||||||||
125226101 | 12522610 | 3 | SS | VANCOMYCIN | VANCOMYCIN | 1 | 1.0 G, EVERY 12 H | 0 | 1 | G | QD |
Indications of drugs used
no results found |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125226101 | 12522610 | DE |
125226101 | 12522610 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125226101 | 12522610 | Drug ineffective | |
125226101 | 12522610 | Streptococcal infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |